Molecular subtyping of small-cell lung cancer (SCLC) has major implications for prognostic relevance and treatment guidance.
This study aimed to explore the feasibility of a novel tracer targeting C-X-C-chemokine-receptor-type-4 (CXCR4) for distinguishing different SCLC subtypes.
